CTRE stock forecast, quote, news & analysis

Key Takeaways

• CareTrust REIT delivered record 2025 results with normalized FFO up 17% year-over-year to $1.76 per share.
• Stock hit new 52-week highs above $41 amid analyst upgrades and positive 2026 guidance.
• Multiple firms raised price targets, with consensus at Moderate Buy and average target around $43.
• $1.8 billion in 2025 investments at 8.6% yields drove revenue growth to $476 million.
• 2026 normalized FFO guidance of $1.90–$1.95 signals 9.4% growth at midpoint.
• Low leverage at 0.7x net debt to EBITDA supports expansion in U.S. and U.K. markets.

Current Market Snapshot

CareTrust REIT (CTRE) has shown robust performance in recent weeks, reaching new 52-week highs amid heightened investor interest in healthcare real estate. The stock has benefited from strong operational results and favorable analyst sentiment, trading near the upper end of its range with elevated volume in recent trading sessions. Fundamentals remain solid, supported by high rent collection rates and a diversified portfolio of net-leased healthcare properties. Broader sector tailwinds in seniors housing and skilled nursing, coupled with the company's conservative balance sheet, have contributed to upward price momentum in the latest market cycle.

Trending AI Robots

Tickeron’s Trending AI Robots page features a curated selection of over 25 high-performing AI trading bots optimized for current market conditions across stocks, ETFs, and crypto. While Tickeron offers hundreds of AI Trading Bots that analyze and trade thousands of different tickers using diverse strategies—from short-term 5-minute scalps to swing trades over days—these trending ones stand out with exceptional recent stats like annualized returns up to 122%, win rates of 70-85%, and profit factors exceeding 2.5. For instance, bots targeting aerospace and semiconductors have delivered 90-119% annualized gains with drawdowns managed effectively. Each bot employs unique styles, timeframes, and ticker sets, backed by AI/ML pattern recognition and risk controls. Explore these top performers to potentially enhance your trading edge in volatile conditions.

Recent Developments Driving CTRE Price Action

CareTrust REIT (CTRE) has experienced significant upward price momentum in recent weeks, propelled by stellar full-year 2025 results and supportive analyst actions. On February 12, the company announced Q4 and full-year operating results, reporting net income of $320.5 million or $1.57 per diluted share for 2025—a 96% year-over-year increase. Normalized FFO reached $359.7 million or $1.76 per share, up 17%, while revenue climbed to $476.4 million. Q4 alone delivered normalized FFO of $104.1 million or $0.47 per share, aligning with estimates but boosted by $561.5 million in investments at an 8.8% stabilized yield. These figures reflected record investment activity totaling $1.8 billion for the year at 8.6% blended yields, including major U.K. acquisitions that expanded the portfolio to 390 properties.

The earnings release also included upbeat 2026 guidance: normalized FFO and FAD of $1.90–$1.95 per share, implying 9.4% growth at the midpoint, based on existing investments, 2.5% rent escalators, and low leverage of 0.7x net debt to annualized run-rate EBITDA. Rent collection stood at 100%, underscoring operational resilience. This strong performance drove initial post-earnings gains, as investors rewarded the company's execution on growth amid healthcare sector demand.

Analyst upgrades amplified the rally. UBS raised its target to $48 with a Buy on February 18; RBC Capital lifted to $44 (Outperform) on February 24; Argus upped to $45 (Buy) recently; Cantor Fitzgerald to $42 (Neutral) on February 17; and earlier hikes from KeyCorp, Wells Fargo, and Goldman Sachs. Consensus now favors Moderate Buy with an average target of $40–43.55, reflecting optimism over the $500 million pipeline and seniors housing (SHOP) expansion. These updates coincided with the stock hitting 52-week highs above $41.72, up over 65% in the past year.

Additionally, CareTrust filed for a $1 billion at-the-market equity program on February 18, signaling confidence in deploying capital accretively without immediate dilution pressure, given $712 million in cash. Macro factors like aging demographics and stable healthcare REIT yields further supported sentiment, though some caution arose from modestly tempered EPS estimates. Overall, these catalysts linked directly to sustained buying interest and price appreciation.

2026 Outlook and Key Factors to Monitor

As CareTrust REIT navigates 2026, investors should track execution on its $1.90–$1.95 normalized FFO guidance, driven by full-year impacts from 2025's $1.8 billion investments and embedded escalators. Portfolio growth in U.K. markets and seniors housing operators (SHOP) represents key opportunities, with a $500 million pipeline poised for deployment at attractive 8-9% yields. Low leverage provides flexibility for further acquisitions amid favorable demographics boosting skilled nursing and seniors demand.

Risks include interest rate sensitivity, given $900 million in debt, and execution on international expansion amid currency fluctuations. Competitive dynamics in healthcare real estate, regulatory changes in reimbursements, and operator performance will influence rent coverage and dispositions. Monitor quarterly investment activity, G&A efficiencies from team investments, and dividend sustainability at a 73% payout ratio. Broader REIT sector trends and economic resilience will also shape positioning.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations